Want to join the conversation?
$ACOR has published results from Phase 1, Phase 2a and preclinical studies of CVT-301, an inhaled form of levodopa, for the treatment of OFF periods in people with Parkinson's disease (PD). PD is a neurodegenerative disorder which results in impaired movement, muscle stiffness and tremors. OFF periods increase as PD progresses.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?